Loading...
XSHG603970
Market cap489mUSD
Jan 10, Last price  
13.36CNY
1D
-2.48%
1Q
-2.62%
IPO
36.33%
Name

Sino-Agri Leading Biosciences Co Ltd

Chart & Performance

D1W1MN
XSHG:603970 chart
P/E
15.97
P/S
0.34
EPS
0.84
Div Yield, %
3.44%
Shrs. gr., 5y
—
Rev. gr., 5y
22.87%
Revenues
10.46b
-10.59%
2,144,799,2052,488,047,6452,875,108,0333,234,190,4733,398,424,8123,503,462,1763,734,627,1724,342,465,2536,640,994,2698,822,111,30711,698,774,53810,459,621,436
Net income
225m
+6.91%
55,462,00668,723,51880,718,87888,266,99781,717,09090,330,227115,459,384118,876,449132,443,776170,309,383210,315,345224,840,982
CFO
-920m
L
109,434,900-79,662,70040,413,7340152,218,146518,829,38065,690,394218,901,571352,123,389325,419,0811,535,609,866-919,851,225
Dividend
Jun 12, 20240.45 CNY/sh
Earnings
May 16, 2025

Profile

Sino-Agri Leading Biosciences Co.,Ltd researches, develops, produces, and distributes agrochemicals in China and internationally. It offers insecticides, fungicides, and herbicides. The company was incorporated in 2009 and is headquartered in Beijing, China. Sino-Agri Leading Biosciences Co.,Ltd is a subsidiary of China National Agricultural Means Of Production Group Corporation.
URL
http://www.sino-agri-sal.com/
IPO date
Nov 16, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
10,459,621
-10.59%
11,698,775
32.61%
Cost of revenue
10,016,233
11,213,311
Unusual Expense (Income)
NOPBT
443,388
485,463
NOPBT Margin
4.24%
4.15%
Operating Taxes
67,548
77,781
Tax Rate
15.23%
16.02%
NOPAT
375,841
407,682
Net income
224,841
6.91%
210,315
23.49%
Dividends
(123,443)
(67,200)
Dividend yield
2.99%
1.19%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
638,913
804,315
Long-term debt
18,900
111,224
Deferred revenue
326
1
Other long-term liabilities
3,955
6,015
Net debt
(1,139,612)
(2,016,183)
Cash flow
Cash from operating activities
(919,851)
1,535,610
CAPEX
(4,368)
Cash from investing activities
225,560
Cash from financing activities
(328,257)
FCF
466
973,856
Balance
Cash
1,656,298
2,931,722
Long term investments
141,128
Excess cash
1,274,444
2,346,783
Stockholders' equity
1,236,707
1,183,730
Invested Capital
1,010,250
1,135,371
ROIC
35.03%
34.42%
ROCE
19.62%
20.79%
EV
Common stock shares outstanding
268,788
268,800
Price
15.36
-26.61%
20.93
12.47%
Market cap
4,128,580
-26.62%
5,625,987
12.47%
EV
3,143,586
3,775,999
EBITDA
465,436
508,867
EV/EBITDA
6.75
7.42
Interest
15,632
26,757
Interest/NOPBT
3.53%
5.51%